Latest news
Theriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 12:11:14 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 12:00:00 GMT